ES2196020T3 - Derivados de triazolobenzazepina antialergicos. - Google Patents

Derivados de triazolobenzazepina antialergicos.

Info

Publication number
ES2196020T3
ES2196020T3 ES94901886T ES94901886T ES2196020T3 ES 2196020 T3 ES2196020 T3 ES 2196020T3 ES 94901886 T ES94901886 T ES 94901886T ES 94901886 T ES94901886 T ES 94901886T ES 2196020 T3 ES2196020 T3 ES 2196020T3
Authority
ES
Spain
Prior art keywords
rent
replaced
halo
alk
represents hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94901886T
Other languages
English (en)
Inventor
Frans Eduard Janssens
Jean Fernand Armand Lacrampe
Isabelle Noelle Consta Pilatte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of ES2196020T3 publication Critical patent/ES2196020T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE PRESENTAN TRIAZOLOBENZOACEPINAS DE LA FORMULA (I), EN DONDE CADA UNA DE LAS LINEAS PUNTEADAS REPRESENTA INDEPENDIENTEMENTE UN ENLACE OPCIONAL; R1 REPRESENTA HIDROGENO, HALO, ALQUIL C1-C4, HIDROXIDO O ALCOXIDO C1-C4; R2 REPRESENTA HIDROGENO, HALO, ALQUIL C1-C4; R3 REPRESENTA HIDROGENO, ALQUIL C1-C4 O HALO; -B D- ES UN RADICAL BIVALENTE DE LA FORMULA -C(R4) N(A-1); O -N C(R5)-(A-2); R4 Y R5 REPRESENTAN HIDROGENO, ALQUIKL C1-C4, ETENIL SUSTITUIDO CON HIDROXICARBONIL O ALQUILOXICARBONIL C1-C4, ALQUIL C1-C4 SUSTITUIDO CON HIDROXICARBONIL O ALQUILOXICARBONIL C1-C4, HIDROXI(C1-C4)ALQUIL, FORMIL O HIDROXICARBONIL; R5 TAMBIEN REPRESENTA FENIL O PIRIDINIL; L REPRESENTA HIDROGENO; ALQUIL C1C6; ALQUIL C1-C6 SUSTITUIDO; ALQUENIL C3-C6; ALQUENIL C3-C6 SUSTITUIDO CON ARIL O, L REPRESENTA UN RADICAL DE LA FORMULA ALK-Y-HET1 (B-1), -ALK-NH-CO-HET2 (B-2) O -ALK-HET3 (B-3). TAMBIEN SE PRESENTAN COMPOSICIONES QUE COMPRENDEN DICHOS COMPUESTOS, PROCESOS PARA PREPARAR LOS MISMOS Y PRODUCTOS INTERMEDIOS EN LA PREPARACION DE LOS MISMOS.
ES94901886T 1992-12-04 1993-11-25 Derivados de triazolobenzazepina antialergicos. Expired - Lifetime ES2196020T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92203776 1992-12-04

Publications (1)

Publication Number Publication Date
ES2196020T3 true ES2196020T3 (es) 2003-12-16

Family

ID=8211104

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94901886T Expired - Lifetime ES2196020T3 (es) 1992-12-04 1993-11-25 Derivados de triazolobenzazepina antialergicos.

Country Status (16)

Country Link
US (1) US5932569A (es)
EP (1) EP0675887B1 (es)
JP (1) JP3572074B2 (es)
KR (1) KR100251893B1 (es)
AT (1) ATE236164T1 (es)
AU (1) AU676701B2 (es)
CA (1) CA2150806C (es)
DE (1) DE69332830T2 (es)
ES (1) ES2196020T3 (es)
FI (1) FI952722A7 (es)
HU (1) HU223464B1 (es)
NO (1) NO305250B1 (es)
NZ (1) NZ258551A (es)
PL (1) PL176593B1 (es)
RU (1) RU2126802C1 (es)
WO (1) WO1994013671A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ258553A (en) * 1992-12-04 1996-06-25 Janssen Pharmaceutica Nv Azepine derivatives; compounds, process for preparation and pharmaceutical compositions containing such compounds
WO2002100862A2 (en) 2001-06-12 2002-12-19 Janssen Pharmaceutica N.V. Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
EP1785424A3 (en) * 2003-04-11 2009-12-23 High Point Pharmaceuticals, LLC Fused 1,2,4-triazoles and pharmaceutical uses thereof
ATE455547T1 (de) * 2003-04-11 2010-02-15 High Point Pharmaceuticals Llc Pharmazeutische verwendungen von kondensierten 1, 2,4-triazolen
RU2239637C1 (ru) * 2003-07-17 2004-11-10 Дж.Б.Кемикалс Энд Фармасьютикалс Лтд. Улучшенный способ получения 5-[2-этокси-5-(4-метилпиперазин-1-илсульфонил)фенил]-1 метил-3-н-пропил-1,6-дигидро-7h-пиразол [4,3-d] пиримидин-7-она
EP1802623A1 (en) * 2004-10-12 2007-07-04 Novo Nordisk A/S 11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds
WO2007051811A2 (en) * 2005-11-01 2007-05-10 Transtech Pharma Pharmaceutical use of substituted amides
EA200801243A1 (ru) * 2005-11-01 2008-10-30 Транстек Фарма Фармацевтическое применение замещенных амидов
EP2007722A1 (en) * 2006-03-21 2008-12-31 High Point Pharmaceuticals, LLC Adamantane derivatives for the treatment of the metabolic syndrome
EP2010479A1 (en) 2006-04-07 2009-01-07 High Point Pharmaceuticals, LLC 11 beta-hydroxysteroid dehydrogenase type 1 active compounds
EP1878721A1 (en) * 2006-07-13 2008-01-16 Novo Nordisk A/S 4-Piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
US8048908B2 (en) * 2006-07-13 2011-11-01 High Point Pharmaceuticals, Llc 11β-hydroxysteroid dehydrogenase type 1 active compounds
ZA200904916B (en) 2007-02-23 2010-09-29 High Point Pharmaceuticals Llc N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
EP2146952A1 (en) * 2007-02-23 2010-01-27 High Point Pharmaceuticals, LLC N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
US8334305B2 (en) * 2007-02-23 2012-12-18 High Point Pharmaceuticals, Llc N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase
US20110003856A1 (en) * 2007-02-23 2011-01-06 Soren Ebdrup N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
US8153798B2 (en) * 2007-03-09 2012-04-10 High Point Pharmaceuticals, Llc Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors
CA2681934A1 (en) * 2007-03-28 2008-10-02 High Point Pharmaceuticals, Llc 11beta-hsd1 active compounds
JP2010523692A (ja) * 2007-04-11 2010-07-15 ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー 新規合成物
ES2393230T3 (es) * 2007-04-24 2012-12-19 High Point Pharmaceuticals, Llc Uso farmacéutico de amidas sustituidas
BR112017003745A2 (pt) 2014-08-29 2017-12-05 Tes Pharma S R L inibidores de semialdeído descarboxilase de ácido alfa-amino-beta-carboximucônico

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1211437A (en) * 1981-08-12 1986-09-16 Rene Borer Benzazepines
US4894372A (en) * 1982-03-17 1990-01-16 Smith Kline & French Laboratories Limited Pyridine compounds which have useful histamine-H2 antagonist activity
EP0552292B1 (en) * 1990-10-10 1995-06-21 Schering Corporation Substituted imidazobenzazepines and imidazopyridoazepines
IL101850A (en) * 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv 11-(4-Piperidinyl)-imidazo (2,1-b) (3) benzazepine derivatives their preparation and pharmaceutical compositions containing them
NZ258553A (en) * 1992-12-04 1996-06-25 Janssen Pharmaceutica Nv Azepine derivatives; compounds, process for preparation and pharmaceutical compositions containing such compounds
CA2150805C (en) * 1992-12-04 2006-08-15 Frans Eduard Janssens Antiallergic imidazo[1,2-a](pyrrolo, thieno or furano)[2,3-d]azepine derivatives

Also Published As

Publication number Publication date
KR100251893B1 (ko) 2000-04-15
HU223464B1 (hu) 2004-07-28
NO952198D0 (no) 1995-06-02
JPH08503952A (ja) 1996-04-30
AU5627894A (en) 1994-07-04
HU9501621D0 (en) 1995-08-28
NO305250B1 (no) 1999-04-26
CA2150806C (en) 2006-01-31
CA2150806A1 (en) 1994-06-23
ATE236164T1 (de) 2003-04-15
EP0675887A1 (en) 1995-10-11
EP0675887B1 (en) 2003-04-02
US5932569A (en) 1999-08-03
DE69332830T2 (de) 2004-01-29
WO1994013671A1 (en) 1994-06-23
PL176593B1 (pl) 1999-06-30
JP3572074B2 (ja) 2004-09-29
DE69332830D1 (de) 2003-05-08
FI952722A0 (fi) 1995-06-02
NZ258551A (en) 1996-06-25
HUT71811A (en) 1996-02-28
PL309253A1 (en) 1995-10-02
RU95114439A (ru) 1997-06-10
NO952198L (no) 1995-08-03
FI952722A7 (fi) 1995-06-02
AU676701B2 (en) 1997-03-20
RU2126802C1 (ru) 1999-02-27

Similar Documents

Publication Publication Date Title
NO20001105L (no) Transgene pattedyr som danner oligosakkarider i melken
AR015103A1 (es) Compuestos derivados de 6,6-heterobiciclicos sustituidos y composiciones que los contienen e intermediarios
ATE85599T1 (de) Substituierte phenyltrifluormethylether.
GR3020451T3 (en) Retroviral protease inhibitors
EP0431302A3 (en) Use of curable cycloaliphatic derivatives in putty compositions
DK0594702T3 (da) Substituerede indoler som midler mod AIDS
HUT48242A (en) Process for producing 2-//piperidin-4-yl/-methyl/-1,2,3,4-tetrahydro9h-pyrido/3,4-b/indol derivatives and pharmaceutical compositions containing them
EP0121233A3 (en) Crystalline aluminophosphate compositions
GR3024586T3 (en) Retroviral protease inhibitors
DK330086A (da) Addukt af cis-diklor-trans-dihydroxy-bis-(isopropylamin)-platin(iv) og fremgangsmaade til fremstilling deraf
ES8405068A1 (es) Un procedimiento para fabricar pastillas de jabon molido.
HUT71811A (en) Triazolobenzazepine derivatives, process for preparing them and antiallergic pharmaceutical compositions containing them
DK55584A (da) Hidtil ukendte carbacykliner, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel
ES2164653T3 (es) Procedimiento para producir heterociclos polihidroxilicos que contienen nitrogeno n-sustituidos.
ES2039195T3 (es) Derivado de la pirazolsulfonamida, procedimiento para su fabricacion y herbicida que lo contiene.
ES2137626T3 (es) Procedimiento para la preparacion de derivados de ciclopentadienilo.
DE3364462D1 (en) Process for the preparation of acemetacin
DE3160388D1 (en) Antiallergic imidodisulfamides, their preparation and pharmaceutical compositions containing them
ES8401962A1 (es) Un procedimiento para la preparacion de un derivado de piridoindol.
GB8416652D0 (en) Penem derivatives
ES2123739T3 (es) Nuevos analogos del eburnano, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ZA876542B (en) Novel 3-methylphtalimides
GR1001203B (el) Μεθοδος παρασκευης της ενωσεως 24r-σκυμνολη.
ES2149548T3 (es) Derivado de hidroquinona y uso farmaceutico del mismo.
GR1001566B (el) Μέ?οδος παρασκευής νέων παραγώγων βενζοφουρανυλιμιδαζόλης.